ACADIA Pharmaceuticals Inc
(NASDAQ:ACAD)
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
top performing ACAD trades
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent ACADIA Pharmaceuticals trades made by congress members.
![]() Chris JacobsHouse (R-NY) | $1K - $15K | stock | Sale | Jul 28, 2022 | Jun 16, 2022 | House |